These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2309983)

  • 1. Aluminum-induced microcytosis in a child with moderate renal insufficiency.
    Shah NR; Oberkircher OR; Lobel JS
    Am J Pediatr Hematol Oncol; 1990; 12(1):77-9. PubMed ID: 2309983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
    Swartz R; Dombrouski J; Burnatowska-Hledin M; Mayor G
    Am J Kidney Dis; 1987 Mar; 9(3):217-23. PubMed ID: 3826071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium carbonate is an effective phosphorus binder in children with chronic renal failure.
    Andreoli SP; Dunson JW; Bergstein JM
    Am J Kidney Dis; 1987 Mar; 9(3):206-10. PubMed ID: 3826069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminium encephalopathy: a potential risk of aluminium gels in children with chronic renal failure.
    Pillion G; Loirat C; Blum C; Poisson M; Bacri JL; Broyer M; Mathieu H
    Int J Pediatr Nephrol; 1981 Mar; 2(1):29-32. PubMed ID: 7333766
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypercalcemia and nephrolithiasis provoked by serum phosphorus reduction in a patient with chronic renal failure and sarcoidosis.
    Caruana RJ; Weinstein RS
    Nephron; 1983; 33(4):271-3. PubMed ID: 6843758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current concepts of the role of aluminum in chronic kidney failure patients].
    Gruev I; Belovezhdov N
    Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pseudo-porphyria cutanea tarda in patients with chronic renal insufficiency and in patients with renal transplants].
    Antonello A; Peserico A; Corsano A; Zannini G; Fagiolo U
    Minerva Chir; 1980 May; 35(10):775-7. PubMed ID: 7005735
    [No Abstract]   [Full Text] [Related]  

  • 8. Aluminum-induced anemia.
    Kaiser L; Schwartz KA
    Am J Kidney Dis; 1985 Nov; 6(5):348-52. PubMed ID: 3904427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB; Foley J; Nelson P; Goodman WG
    N Engl J Med; 1991 Feb; 324(8):527-31. PubMed ID: 1992306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What treatment would you advise for a 1-year-old child with chronic renal failure who has been on aluminum hydroxide as a phosphate binder for 6 months and then develops epilepsy and is found to have a grossly raised plasma aluminum concentration?
    Andreoli SP; Chesney RW; Salusky IB; Sedman AB
    Pediatr Nephrol; 1990 Jul; 4(4):318. PubMed ID: 2206897
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypercalcemia and hyperaluminemia in children with chronic renal insufficiency].
    Hinojosa-Lezama M; Gordillo-Paniagua G; Muñoz-Arizpe R; Mercado-Polo L
    Bol Med Hosp Infant Mex; 1987 Sep; 44(9):535-9. PubMed ID: 3663320
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudohyperparathyroidism. Syndrome associated with aluminum intoxication in patients with renal failure.
    Sherrard DJ; Ott SM; Andress DL
    Am J Med; 1985 Jul; 79(1):127-30. PubMed ID: 4014298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
    Válek A; Sulková S; Laurinová Z
    Ter Arkh; 1991; 63(6):89-93. PubMed ID: 1948757
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies.
    Touam M; Martinez F; Lacour B; Bourdon R; Zingraff J; Di Giulio S; Drüeke T
    Clin Nephrol; 1983 Jun; 19(6):295-8. PubMed ID: 6872366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stercoral peritonitis. Unusual complication of treatment by aluminum gels in patients with renal insufficiency under long-term hemodialysis].
    Salmon R; Aubert P; David R; Guédon J
    Med Chir Dig; 1979; 8(4):329-31. PubMed ID: 502625
    [No Abstract]   [Full Text] [Related]  

  • 16. Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide.
    Griswold WR; Reznik V; Mendoza SA; Trauner D; Alfrey AC
    Pediatrics; 1983 Jan; 71(1):56-8. PubMed ID: 6848980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication.
    Caramelo CA; Cannata JB; Rodeles MR; Fernández Martín JL; Mosquera JR; Monzú B; Outeiriño J; Blum G; Andrea C; Lopez Farré AJ
    Kidney Int; 1995 Jan; 47(1):164-8. PubMed ID: 7731142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis.
    Salusky IB; Coburn JW; Foley J; Nelson P; Fine RN
    J Pediatr; 1986 May; 108(5 Pt 1):767-70. PubMed ID: 3701525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowel obstruction occurring in a child during treatment with aluminum hydroxide gel.
    Hurley JK
    J Pediatr; 1978 Apr; 92(4):592-3. PubMed ID: 633020
    [No Abstract]   [Full Text] [Related]  

  • 20. Aluminum toxicity in relation to kidney disorders.
    King SW; Savory J; Wills MR
    Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.